EpiBone

EpiBone is a biomedical engineering company that is developing technology to create bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.[1][2]

History

EpiBone was founded in 2013 by Nina Tandon and Sarindr “Ik” Bhumiratana in New York City.[3] The company’s technology derives from research in bone and osteochondral tissue engineering at Columbia University.[4]

See also

References

  1. ^ "This Woman's Revolutionary Startup Could Change 900,000 Surgeries A Year". Business Insider. Retrieved 2015-10-20.
  2. ^ "EpiBone". Retrieved 2022-04-07.
  3. ^ "This Startup Wants People to Grow Their Own Bone Transplants". Bloomberg.com. Archived from the original on 2022-12-03. Retrieved 2025-09-07.
  4. ^ Murphy, Sean V.; Atala, Anthony (2016). Regenerative Medicine Technology: On-a-Chip Applications for Disease Modeling, Drug Discovery and Personalized Medicine. CRC Press. p. 407. ISBN 9781498711920.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.